Report ID: SQMIG35D2259
Report ID:
SQMIG35D2259 |
Region:
Global |
Published Date: March, 2024
Pages:
198
|
Tables:
87 |
Figures:
76
In October 2023, “Skinvive”, the first injectable of its kind was launched in the U.S. Skinvive, is a new hyaluronic acid filler approved by the FDA in May 2023.
In November 2023, Mibelle launched RejuveNAD, a natural NAD+ booster for skin care. NAD+ is the oxidized form of Nicotinamide adenine dinucleotide (NAD), a coenzyme central to metabolism. NAD+ plays a crucial role in various cellular processes and has received significant attention in anti-aging supplements.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35D2259